echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Food Articles > Abcam acquires Expedeon's proteomics and immunology business

    Abcam acquires Expedeon's proteomics and immunology business

    • Last Update: 2021-03-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    , including leading protein-coupled technologies and industry brands Lightning-Link® and CaptSureTM
    , have the opportunity to develop new products by integrating Expedeon and Abcam technologies to support research and diagnostic development
    Cambridge, UK - January 2020 6: Abcam plc, a global innovator in life sciences reagents and tools, is pleased to announce that as of January 1, 2020, Abcam has successfully completed acquisitions of Expedeon's proteomics and immunology businesses, including Innova and TGR Biosciences. Abcam and Expedeon remain committed to providing Expedeon proteomics and immunology-related products and support to ensure ongoing research and development in the life sciences community.

    , Vice President of Product Portfolio and Innovation at abcam, said, "As innovators in bio-reagents, we are able to deliver these technologies quickly and globally with a dedicated, globally commercialized infrastructure. Over the years, we have had teams dedicated to joint research, and the integration of this expertise with Expedeon's portfolio and other complementary coupled technologies, including BrickBio's related technologies, has provided us with a very powerful platform to provide the sophisticated research tools we need to meet most of today's and future emerging life sciences testing. Ms. zhang Wei, general manager of
    Abcam China, said of the acquisition: "The acquisition of Expedeon by
    means that Abcam has protein-coupled technology that completes Abcam's product line and maintains industry leadership." The close cooperation between the two will make Abcam a larger platform to further enhance Abcam's overall operational capabilities in China, expand its global reach and maintain its leading technology research and development resources in the life sciences industry, and continue to provide chinese customers with the world's leading technical support and customer service experience.
    protein markers are key to the biology of proteomics, with 84% of researchers looking for solutions to support coupledity. Proteomics research requires the use of molecular markers that can be co-priced with the target protein to facilitate the detection or purification of the protein or its binding partner. With more than 50 label types of connected kits for life sciences applications, Expedeon technology supports a wide range of labels, including enzymes, metals, oligonucleotides and fluorescent proteins. Abcam will integrate its newly acquired capture and federation technology with its extensive antibody and protein expertise to expand and enhance its portfolio of customized and non-customized reagents and tools.as a global life sciences company, Abcam is committed to discovering, developing and selling high-quality biological reagents and tools that are critical to research, drug development and diagnostics. The company is working with industry partners to support life scientists to achieve their goals faster.
    with its proprietary development platform and world-leading antibody expertise, Abcam has teamed up with a number of life sciences organizations to create innovative bioysynthetics for drug development, in-body diagnostics and treatment.
    through innovative bio-combinations and test kits, Abcam is helping to improve global understanding of biology and causes, driving the application and health of new therapies. The company's innovative data sharing approach gives scientists more confidence in their findings by providing validation, user reviews, and peer-reviewed opinions on more than 100,000 products.
    Abcam's global service and support network is further improved with ten locations and a strong team of 1,100 employees at the world's leading life sciences research center.
    for more information, please visit the
    and
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.